logo
Select company
Select metric
Ticker Information

Ticker

OGEN

Company Name

ORAGENICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

ORAGENICS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

OGEN - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -9.51M0%$ 0
3/31/2025$ -10.11M0%$ 0
12/31/2024$ -10.54M0%$ 0
9/30/2024$ -19.94M0%$ 0
6/30/2024$ -19.48M-260864.76%$ 7.47K
3/31/2024$ -20.21M-97975.26%$ 20.63K
12/31/2023$ -20.6M-54704.15%$ 37.65K
9/30/2023$ -10.08M-26774.52%$ 37.65K
6/30/2023$ -11.94M-10272.05%$ 116.23K
3/31/2023$ -12.48M-9350.62%$ 133.46K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for ORAGENICS INC is calculated as follows: EBITDA [ $ -25.55M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

OGEN - EBITDA Margin, Last 5 years

-260864.76%

Minimum

Jun 30, 2024

-7425.77%

Maximum

Sep 30, 2022

-47720.38%

Average

-16139.56%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%